FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

773879000: Antineoplastic therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3726859011 Antineoplastic therapeutic role en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3726860018 Antineoplastic therapeutic role (role) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antineoplastic therapeutic role est un(e) (attribut) Therapeutic role (role) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely bendamustine hydrochloride 25 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Aminolevulinic acid hydrochloride (as 5-aminolevulinic acid) 30 mg/mL oral solution Plays role True Antineoplastic therapeutic role Inferred relationship Some
5-aminolevulinic acid-containing product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
5-aminolevulinic acid only product in oral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely trastuzumab 60 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely hydroxycarbamide 100 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely triptorelin (as triptorelin pamoate) 11.25 milligram/1 vial powder for conventional release suspension for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely carfilzomib 60 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely carfilzomib 10 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely carfilzomib 30 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely leuprorelin acetate 60 milligram/1 milliliter conventional release suspension for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Ruxolitinib (as ruxolitinib phosphate) 25 mg oral tablet Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely vinorelbine (as vinorelbine tartrate) 10 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Arsenic trioxide 1 mg/mL solution for infusion and/or injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely arsenic trioxide 2 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Brentuximab vedotin 50 mg powder for solution for infusion and/or injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely cladribine 1 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely fluorouracil (as fluorouracil sodium) 50 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely ipilimumab 5 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Irinotecan hydrochloride trihydrate 20 mg/mL solution for infusion and/or injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely epirubicin hydrochloride 2 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Trastuzumab emtansine 160 mg powder for solution for infusion and/or injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely rituximab 10 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely doxorubicin hydrochloride 2 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Alemtuzumab only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Alemtuzumab-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing only clofarabine in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Clofarabine-containing product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Mitoxantrone only product in parenteral dose form Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing mitoxantrone in parenteral dose form (medicinal product form) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely mitoxantrone (as mitoxantrone hydrochloride) 2 milligram/1 milliliter conventional release solution for infusion (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely alemtuzumab 10 milligram/1 milliliter conventional release solution for infusion (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely clofarabine 1 milligram/1 milliliter conventional release solution for infusion (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Dacarbazine (as dacarbazine citrate) 1 g powder for solution for infusion vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely dacarbazine (as dacarbazine citrate) 500 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely dacarbazine (as dacarbazine citrate) 200 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Decitabine 50 mg powder for solution for infusion vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely obinutuzumab 25 milligram/1 milliliter conventional release solution for infusion (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely gemcitabine (as gemcitabine hydrochloride) 40 milligram/1 milliliter conventional release solution for infusion (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely cetuximab 5 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely fludarabine phosphate 25 milligram/1 milliliter conventional release solution for infusion (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Gemcitabine (as gemcitabine hydrochloride) 38 mg/mL solution for infusion Plays role True Antineoplastic therapeutic role Inferred relationship Some
Gemcitabine (as gemcitabine hydrochloride) 100 mg/mL solution for infusion Plays role True Antineoplastic therapeutic role Inferred relationship Some
Decitabine 50 mg powder for solution for infusion and/or injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Paclitaxel (as albumin bound paclitaxel) 100 mg powder for dispersion for infusion vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely paclitaxel (as albumin bound paclitaxel) 250 milligram/1 vial powder for conventional release dispersion for infusion (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Daratumumab 120 mg/mL solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely azacitidine 100 milligram/1 vial powder for conventional release suspension for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some
Carmustine 100 mg powder for solution for infusion and/or injection vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Carmustine 100 mg powder for solution for infusion vial Plays role True Antineoplastic therapeutic role Inferred relationship Some
Fluorouracil (as fluorouracil sodium) 25 mg/mL solution for infusion and/or injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Interferon beta-1a 44 microgram/mL solution for injection Plays role True Antineoplastic therapeutic role Inferred relationship Some
Product containing precisely interferon beta-1a 88 microgram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antineoplastic therapeutic role Inferred relationship Some

Start Previous Page 16 of 16

This concept is not in any reference sets

Back to Start